Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796583 · ClinicalTrials.gov registry record · NA
Pulsed Shortwave Therapy for Postoperative Analgesia
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT05796583 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 70 participants.
The verdict
NCT05796583, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
Pulsed shortwave (radiofrequency) therapy is a possible method of pain control involving the application of electromagnetic energy (also termed pulsed electromagnetic fields). Food and Drug Administration-cleared devices have been in clinical use for over 70 years. For decades, available devices consisted of a large signal generator and bulky coil applicator that were not portable and produced significant electromagnetic interference, making them impractical for common use. However, small, lightweight, relatively inexpensive, noninvasive, Food and Drug Administration-cleared devices that function for 8 days are now available to treat acute and chronic pain, decrease inflammation and edema, and hasten wound healing and bone regeneration. Therefore, it has the potential to concurrently improve analgesia and decrease or even negate opioid requirements, only without the limitations of opioids and peripheral nerve blocks. The purpose of this study is to explore the possibility of treating acute postoperative pain with nonthermal, pulsed shortwave (radiofrequency) therapy, optimize the study protocol, and estimate the treatment effect.
Interventions
- DEVICE Sham Treatment
- DEVICE Active Pulsed Shortwave Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-04-04 |
| Est. Completion | 2024-10-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796583
The ClinicalTrials.gov registry entry for NCT05796583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT05796583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05796583 about?
NCT05796583 is a clinical study titled "Pulsed Shortwave Therapy for Postoperative Analgesia". Pulsed shortwave (radiofrequency) therapy is a possible method of pain control involving the application of electromagnetic energy (also termed pulsed electromagnetic fields). Food and Drug Administration-cleared devices have been in clinical use for over 70 years. For decades, available devices con...
What is the current status of trial NCT05796583?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2023-04-04. Estimated completion is 2024-10-20.
What interventions are being tested in trial NCT05796583?
The interventions under investigation include: Sham Treatment (DEVICE), Active Pulsed Shortwave Treatment (DEVICE).
Who is sponsoring clinical trial NCT05796583?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.